Extreme Biotech: Understanding Extremophile Biology to Impact Human Health
Recorded
Tuesday, September 22, 2020 · 2:30 p.m.
ABOUT THIS WEBINAR
Extremophiles are best known to scientists for their contributions to PCR, but researchers are now harnessing the power of their unique biology to create new therapeutics from vaccine delivery to anti-cancer drugs. In this webinar from The Scientist, extremophile researchers Shiladitya DasSarma and Jaclyn Winter will discuss how they harness the unique biology of extremophiles for the discovery and development of new therapeutics and vaccines.
Topics to be covered:
• Harnessing the chemical potential of unprecedented microbes from the Great Salt Lake
• Archaeal nanoparticles for therapeutics and vaccines
Education & learning
ADDITIONAL INFO
Categories:
Education & learning
When:
Tuesday, September 22, 2020 · 2:30 p.m.
Eastern Time (US & Canada)
Duration: 1 hour 30 minutes
Price:Free
Language:English
Who can attend?Anyone with the event link can attend
Assistant Professor, Department of Medicinal Chemistry, University of Utah
Jackie Winter obtained her B.S. in chemistry and molecular genetics from SUNY Fredonia and obtained her Ph.D. in marine natural product biosynthesis under the guidance of Dr. Bradley Moore at Scripps Institution of Oceanography. Her dissertation...
Professor, Department of Microbiology and Immunology, University of Maryland School of Medicine, Professor, Institute of Marine and Environmental Technology, University System of Maryland
Dr. DasSarma earned his PhD from the Massachusetts Institute of Technology with Nobel laureate HG Khorana, and received his postdoctoral training at Massachusetts General Hospital, Harvard Medical School. He served as a faculty member in the...